Innovation
-
Rallying innovation in the age of Covid-19
When it comes to innovations in the face of global pandemics, business as usual for our innovation system is unlikely to apply. There are strong pressures to make it freely available, and in the process, push down the return to any R&D that has been conducted
-
Special Briefing: Indegene CEO Manish Gupta talks about the next phase of digitalisation in pharma
From an ahead-of-its-times outfit to bring technology to 'medico marketing' to a multinational tech company offering AI and NLP platforms to the world's biggest drugmakers, Indegene has come a long way. The Covid-19 pandemic, however, showed that the Bengaluru company was only getting started. In this special briefing, Manish Gupta, co-founder and CEO of Indegene, recalls the early days of Indegene, and talks about what lies ahead
-
In 2021, consumers are craving products that deliver novelty and fun
After a year of buying boring staples in bulk, everything is about to change—and brands need to be ready to innovate
-
Drones centralise vaccine storage, reduce expensive refrigerated shipping: Zipline's Dan Czerwonka
Medical delivery firm Zipline has been working in Ghana and Rwanda to transport Covid-19 and other vaccines. Its head of global regulatory affairs Dan Czerwonka speaks about the advantages and challenges of deploying unmanned aircraft systems in other countries
-
How a clutch of startups is taking healthcare to rural India
Through innovation and pivots, these startups are helping rural India, which has little or no access to healthcare including, hospitals, doctors, diagnostics, or medicines, cope with the pandemic
-
India's pharma companies are readying 900 million doses of Sputnik V. Can it pull the country out of its Covid-19 mess?
Amid concerns surrounding Sputnik V and the launch of a single-dose vaccine, Indian companies, including Hetero, Stelis, Biopharma and Gland Pharma are on track to make millions of doses of the Russian vaccine in a bid to alleviate the country's supply constraints
-
Supporting long duration R&D programs to avoid time compression diseconomies
The first Covid-19 vaccine came in record time but it's easy to forget the decades of research into mRNA, which underpins the Pfizer-BioNTech vaccine
-
Industry 4.0: India's urgent need to make the revolution green
As millions are poured into digital transformation to survive the pandemic economy, augmenting sustainability alongside digital capabilities is an economic, competitive and global opportunity for India's businesses. But regulations need to reflect intent
-
Creating urgency around corporate innovation
What intrapreneurs in established firms must do to succeed
-
This entrepreneur is building Covid care hospitals in rural areas of North India
Shriti Pandey, 29, is helping construct health care facilities at a faster pace in remote locations using sustainable materials derived from agricultural waste
-
Future of Money—Digitalisation will help in value creation: Gaurav Deepak
As the pandemic brings technology and innovation to the core of business and daily life, the next decade will see about 150 million digital-first families in India, writes the cofounder and CEO of Avendus Capital